Triple threat: new antibody takes on tough tumors
NCT ID NCT06741644
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 29 times
Summary
This study tests a new drug called CS2009, which targets three different proteins on cancer cells to help the immune system fight tumors. It is for people with advanced solid tumors that have not responded to other treatments. The trial has two parts: first, finding the safest dose, and then testing how well it works alone or with other drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alfred Hospital (Alfred Health)
RECRUITINGMelbourne, Australia
-
Anhui Provincial Hospital
RECRUITINGHefei, China
-
Austin Hospital (Austin Health)
RECRUITINGMelbourne, Australia
-
Beijing Cancer Hospital
RECRUITINGBeijing, China
-
Blacktown Hospital
RECRUITINGSydney, Australia
-
Central Hospital Affiliated to Shandong First Medical University
RECRUITINGJinan, China
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, China
-
Fujian Cancer Hospital
RECRUITINGFuzhou, China
-
Harbin Medical University Cancer Hospital
RECRUITINGHarbin, China
-
Henan Cancer Hospital
RECRUITINGZhengzhou, China
-
Hunan Cancer Hospital
NOT_YET_RECRUITINGChangsha, China
-
Icon Cancer Centre South Brisbane
RECRUITINGSouth Brisbane, Australia
-
Jilin Cancer Hospital
RECRUITINGChangchun, China
-
Linyi Cancer Hospital
RECRUITINGLinyi, China
-
Macquarie University Hospital
RECRUITINGSydney, Australia
-
Monash Medical Centre (Monash Health)
RECRUITINGMelbourne, Australia
-
Nanjing Drum Tower Hospital
RECRUITINGNanjing, China
-
Peter Maccallum Cancer Centre Research
RECRUITINGMelbourne, Australia
-
Scientia Clinical Research Ltd
RECRUITINGSydney, Australia
-
Shanghai East Hospital
RECRUITINGShanghai, China
-
Shanghai Pulmonary Hospital
RECRUITINGShanghai, China
-
Sichuan Cancer Hospital
RECRUITINGChengdu, China
-
Sun Yat-Sen University Cancer Center
NOT_YET_RECRUITINGGuangzhou, China
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
RECRUITINGGuangzhou, China
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, China
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, China
-
The First Affiliated Hospital, Zhejiang University School of Medicine
NOT_YET_RECRUITINGHangzhou, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, China
-
West China Hospital of Sichuan University
RECRUITINGChengdu, China
-
Xuzhou Central Hospital
RECRUITINGXuzhou, China
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, China
Conditions
Explore the condition pages connected to this study.